MK-2420 SAD Study
Phase 1
Completed
- Conditions
- Rheumatoid arthritis
- Registration Number
- 2024-511297-73-00
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ended
- Sex
- Not specified
- Target Recruitment
- 96
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
UZ Leuven
🇧🇪Leuven, Belgium
Universitair Ziekenhuis Gent
🇧🇪Gent, Belgium
UZ Leuven🇧🇪Leuven, BelgiumJan de HoonSite contact+3216342020jan.dehoon@uz.kuleuven.ac.be